Cross-source evidence timeline
Avexitide research timeline
Follow 3 selected, directly cited source records from July 18, 2022 through August 24, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Clinical trials
ClinicalTrials.gov record NCT06747468↗
PeptideScanner retained ClinicalTrials.gov record NCT06747468 at 2026-11-16T01:46:44.871Z. Its registry update date was 2026-08-24, and PeptideScanner's reviewed identity mapping was avexitide.↗
Added to PeptideScanner November 16, 2026
Source year
2023
Clinical trials
ClinicalTrials.gov record NCT04652479↗
PeptideScanner retained ClinicalTrials.gov record NCT04652479 at 2026-11-16T01:46:44.871Z. Its registry update date was 2023-06-09, and PeptideScanner's reviewed identity mapping was avexitide.↗
Added to PeptideScanner November 16, 2026
Source year
2022
Clinical trials
ClinicalTrials.gov record NCT03373435↗
PeptideScanner retained ClinicalTrials.gov record NCT03373435 at 2026-11-16T01:46:44.871Z. Its registry update date was 2022-07-18, and PeptideScanner's reviewed identity mapping was avexitide.↗
Added to PeptideScanner November 16, 2026